<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.7804</article-id>
<article-id pub-id-type="publisher-id">mmr-16-06-9763</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Protective effects of rosmarinic acid against hydrogen peroxide-induced cellular senescence and the inflammatory response in normal human dermal fibroblasts</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Hahn</surname><given-names>Hyung Jin</given-names></name>
<xref rid="af1-mmr-16-06-9763" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ki Bbeum</given-names></name>
<xref rid="af2-mmr-16-06-9763" ref-type="aff">2</xref>
<xref rid="af3-mmr-16-06-9763" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>An</surname><given-names>In-Sook</given-names></name>
<xref rid="af2-mmr-16-06-9763" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Ahn</surname><given-names>Kyu Joong</given-names></name>
<xref rid="af1-mmr-16-06-9763" ref-type="aff">1</xref>
<xref rid="fn1-mmr-16-06-9763" ref-type="author-notes">&#x002A;</xref>
<xref rid="c1-mmr-16-06-9763" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Han</surname><given-names>Hyun Joo</given-names></name>
<xref rid="af3-mmr-16-06-9763" ref-type="aff">3</xref>
<xref rid="fn1-mmr-16-06-9763" ref-type="author-notes">&#x002A;</xref>
<xref rid="c2-mmr-16-06-9763" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-16-06-9763"><label>1</label>Department of Dermatology, Konkuk University School of Medicine, Seoul 05030, Republic of Korea</aff>
<aff id="af2-mmr-16-06-9763"><label>2</label>GeneCellPharm Corporation, Seoul 05836, Republic of Korea</aff>
<aff id="af3-mmr-16-06-9763"><label>3</label>Department of Biological Engineering, Graduate School of Engineering, Konkuk University, Seoul 05029, Republic of Korea</aff>
<author-notes>
<corresp id="c1-mmr-16-06-9763"><italic>Correspondence to</italic>: Professor Kyu Joong Ahn, Department of Dermatology, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 05030, Republic of Korea, E-mail: <email>kjahn@kuh.ac.kr</email></corresp>
<corresp id="c2-mmr-16-06-9763">Dr Hyun Joo Han, Department of Biological Engineering, Graduate School of Engineering, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Republic of Korea, E-mail: <email>bonamie@hanmail.net</email></corresp>
<fn id="fn1-mmr-16-06-9763"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub"><month>12</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>17</day><month>10</month><year>2017</year></pub-date>
<volume>16</volume>
<issue>6</issue>
<fpage>9763</fpage>
<lpage>9769</lpage>
<history>
<date date-type="received"><day>16</day><month>08</month><year>2016</year></date>
<date date-type="accepted"><day>23</day><month>08</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) is a reactive oxygen species (ROS) that induces numerous cellular events, including cellular senescence and inflammatory responses. Therefore, the aim of this study was to investigate the protective effect of Rosmarinic acid (RA) in H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in normal human dermal fibroblasts (NHDFs). Cytotoxicity assays were performed using a water-soluble tetrazolium salt, and senescence-associated &#x03B2;-galactosidase activity was determined to investigate the proportion of senescent cells. Antioxidant capacities were evaluated via H<sub>2</sub>O<sub>2</sub>-scavenging activity, reverse transcription-quantitative polymerase chain reaction, NRF2 luciferase reporter gene activity and intracellular ROS scavenging assays. Cytokine-coded gene expression analysis and nuclear factor-&#x03BA;B luciferase activity were determined to verify the anti-inflammatory effect of RA. As a result, the present study demonstrated that rosmarinic acid inhibited H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and inflammatory responses in normal human dermal fibroblasts. Initially, the doses of RA that exerted minimal cytotoxic effects in NHDFs were determined using a cytotoxicity assay. Subsequently, pretreatment with the appropriate doses of RA significantly reversed the H<sub>2</sub>O<sub>2</sub>-induced decrease in NHDF cell viability and decreased cellular senescence of NHDFs. In addition, RA inhibited H<sub>2</sub>O<sub>2</sub>-induced ROS production in NHDFs, as determined by a ROS scavenging assay. The protective effects of RA were mediated by the inhibition of nuclear factor erythroid-derived 2-like 2, a transcription factor that functions as a key regulator of redox sensitivity. Furthermore, RA suppressed H<sub>2</sub>O<sub>2</sub>-induced inflammation in NHDFs and significantly rescued H<sub>2</sub>O<sub>2</sub>-induced downregulation of sirtuin 1. RA also inhibited nuclear factor (NF)-&#x03BA;B transcriptional activity and the expression of NF-&#x03BA;B target genes, including tumor necrosis factor-&#x03B1; and interleukin-6, in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs. Taken together, these data indicate that RA inhibits H<sub>2</sub>O<sub>2</sub>-induced cellular damage in NHDFs.</p>
</abstract>
<kwd-group>
<kwd>hydrogen peroxide</kwd>
<kwd>inflammatory response</kwd>
<kwd>oxidative stress</kwd>
<kwd>dermal fibroblasts</kwd>
<kwd>rosmarinic acid</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>The term reactive oxygen species (ROS) refers to all chemically reactive molecules containing an oxygen atom, including oxygen radicals and non-radicals. The various types of ROS are classified as either endogenous mitochondrial factors or extracellular factors (<xref rid="b1-mmr-16-06-9763" ref-type="bibr">1</xref>). Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) is a reactive byproduct of the electron transport chain in mitochondria (<xref rid="b1-mmr-16-06-9763" ref-type="bibr">1</xref>).</p>
<p>The skin is the largest organ of the body; it surrounds the body and protects it from the external environment. Extrinsic stimuli, including ultraviolet (UV) light, pollution and thermal stress, disrupt skin cell metabolism, thereby disrupting redox state equilibrium (<xref rid="b2-mmr-16-06-9763" ref-type="bibr">2</xref>). Although cells employ efficient enzymatic and nonenzymatic antioxidant mechanisms, excessive ROS production can induce lipid peroxidation, DNA damage and protein denaturation (<xref rid="b1-mmr-16-06-9763" ref-type="bibr">1</xref>). Proteins associated with conventional enzyme-mediated antioxidant mechanisms include superoxide dismutase (SOD), glutathione peroxidase and catalase (CAT) (<xref rid="b1-mmr-16-06-9763" ref-type="bibr">1</xref>). These enzymes are primarily activated in response to ROS. In H<sub>2</sub>O<sub>2</sub>-exposed normal human dermal fibroblasts (NHDFs), excessive ROS production disrupts antioxidant defense mechanisms and induces the inflammatory response (<xref rid="b1-mmr-16-06-9763" ref-type="bibr">1</xref>,<xref rid="b3-mmr-16-06-9763" ref-type="bibr">3</xref>).</p>
<p>In its inactive form in the cytoplasm, nuclear factor erythroid-derived 2-like 2 (NRF2) interacts with Kelch-like-ECH-associated protein 1 (<xref rid="b4-mmr-16-06-9763" ref-type="bibr">4</xref>). A disruption in this interaction by factors, including ROS, activates the NRF2 signaling pathway (<xref rid="b4-mmr-16-06-9763" ref-type="bibr">4</xref>). Activated NRF2 translocates to the nucleus where it binds to antioxidant response element (ARE), and initiates the transcription of genes associated with the response to oxidative stress, including heme oxygenase-1 (<italic>HO-1</italic>), <italic>SOD</italic> and <italic>CAT</italic> (<xref rid="b5-mmr-16-06-9763" ref-type="bibr">5</xref>&#x2013;<xref rid="b7-mmr-16-06-9763" ref-type="bibr">7</xref>).</p>
<p>The mammalian Sir2 ortholog, sirtuin 1 (SIRT1), is a histone deacetylase that targets histones and nonhistone substrates, including nuclear factor (NF)-&#x03BA;B and p53 (<xref rid="b8-mmr-16-06-9763" ref-type="bibr">8</xref>,<xref rid="b9-mmr-16-06-9763" ref-type="bibr">9</xref>). Previous studies have demonstrated that SIRT1 is associated with the regulation of numerous cellular processes, including inflammation, apoptosis and autophagy (<xref rid="b10-mmr-16-06-9763" ref-type="bibr">10</xref>&#x2013;<xref rid="b12-mmr-16-06-9763" ref-type="bibr">12</xref>). Under conditions of adaptive stress, including hypoxia, infection and caloric restriction, SIRT1 inhibits the proinflammatory cytokine NF-&#x03BA;B (<xref rid="b13-mmr-16-06-9763" ref-type="bibr">13</xref>). NF-&#x03BA;B serves a dominant role in inducing the inflammatory response (<xref rid="b14-mmr-16-06-9763" ref-type="bibr">14</xref>,<xref rid="b15-mmr-16-06-9763" ref-type="bibr">15</xref>). In response to excessive cellular stress, activated NF-&#x03BA;B directly activates the expression of genes encoding key inflammatory cytokines, including interleukin (IL)-6 and tumor necrosis factor (TNF)-&#x03B1; (<xref rid="b16-mmr-16-06-9763" ref-type="bibr">16</xref>).</p>
<p>The use of the plant secondary metabolite rosmarinic acid (RA) has been studied in pharmaceutical and dietary supplements in Alzheimer&#x0027;s disease, atopic dermatitis and cardiovascular disease (<xref rid="b17-mmr-16-06-9763" ref-type="bibr">17</xref>&#x2013;<xref rid="b21-mmr-16-06-9763" ref-type="bibr">21</xref>). Previous research has revealed that the effects of RA in these contexts are mediated by its antioxidant properties. One report demonstrated that the antioxidant activity of RA is able to inhibit UV-induced damage in the skin of mice (<xref rid="b22-mmr-16-06-9763" ref-type="bibr">22</xref>). In addition, RA may protect human melanoma cells from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress (<xref rid="b23-mmr-16-06-9763" ref-type="bibr">23</xref>). Other reports have also demonstrated that RA protects human keratinocyte HaCaT cells from UVB-induced oxidative stress (<xref rid="b24-mmr-16-06-9763" ref-type="bibr">24</xref>,<xref rid="b25-mmr-16-06-9763" ref-type="bibr">25</xref>). However, the effects of RA on NHDFs, which are the key mediators of skin firmness and elasticity, remain unclear. The present study aimed to investigate the effects of RA on H<sub>2</sub>O<sub>2</sub>-exposed NHDFs.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell culture and treatment</title>
<p>NHDFs (Lonza Group, Ltd., Basel, Switzerland) and the NF-&#x03BA;B Luciferase Reporter NIH3T3 Stable Cell Line (Signosis, Inc., Santa Clara, CA, USA) were cultured in Dulbecco&#x0027;s modified Eagle&#x0027;s medium (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10&#x0025; fetal bovine serum (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and 1&#x0025; penicillin/streptomycin (Thermo Fisher Scientific, Inc.) at 37&#x00B0;C in an atmosphere containing 5&#x0025; CO<sub>2</sub>. H<sub>2</sub>O<sub>2</sub> (Sigma-Aldrich; Merck KGaA) was diluted in phosphate-buffered saline (PBS) to obtain a 1 M stock solution. For the H<sub>2</sub>O<sub>2</sub> treatment experiments, the H<sub>2</sub>O<sub>2</sub> stock solution was diluted in cell culture media at the indicated concentrations. RA (Sigma-Aldrich; Merck KGaA) was dissolved in dimethyl sulfoxide (Sigma-Aldrich; Merck KGaA).</p>
</sec>
<sec>
<title>Cell viability assay</title>
<p>Cytotoxicity was evaluated using a water-soluble tetrazolium salt (WST-1) assay (EZ-Cytox Cell Viability Assay kit; Itsbio, Seoul, Korea). NHDFs were seeded on 96-well culture plates at a density of 3&#x00D7;10<sup>3</sup> cells and were incubated for 24 h, at 37&#x00B0;C. Subsequently, the cells were incubated with RA (0&#x2013;50 &#x00B5;M) for 12 h, after which the cytotoxicity of RA was assessed. To examine the effects of RA against H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity, NHDFs were incubated with the indicated concentration of RA (10, 20 and 30 &#x00B5;M) for 12 h prior to H<sub>2</sub>O<sub>2</sub> treatment. After 12 h, 600 &#x00B5;M of H<sub>2</sub>O<sub>2</sub> was added and incubated at 37&#x00B0;C for 2 h. 1/10 volume of WST-1 solution was then added to each well, and the cells were incubated at 37&#x00B0;C for 1 h. Cell viability was evaluated by measuring absorbance at 450 nm using an iMark microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA).</p>
</sec>
<sec>
<title>H<sub>2</sub>O<sub>2</sub> scavenging activity assay</title>
<p>The H<sub>2</sub>O<sub>2</sub> scavenging activity of RA was evaluated as previously described (<xref rid="b26-mmr-16-06-9763" ref-type="bibr">26</xref>). A solution containing H<sub>2</sub>O<sub>2</sub> (40 mM in distilled water, pH 7.4) and varying concentrations of RA (0&#x2013;1 mg/ml) was incubated at room temperature for 10 min. Scavenger activity was subsequently assessed by measuring the absorbance of the H<sub>2</sub>O<sub>2</sub>/RA solution at 230 nm using a UV spectrophotometer (Shimadzu Corporation, Kyoto, Japan). A solution lacking H<sub>2</sub>O<sub>2</sub> was used as a control, and L-ascorbic acid was used as the experimental control treatment. The experiments were conducted in triplicate at each concentration of RA. Scavenger activity was calculated using the following formula: H<sub>2</sub>O<sub>2</sub> scavenging activity (&#x0025;) = (1 - sample/control) &#x00D7; 100.</p>
</sec>
<sec>
<title>Intracellular ROS scavenging assay</title>
<p>Intracellular ROS production was evaluated using a 2&#x2032;7&#x2032;-dichlorofluorescein diacetate (DCF-DA; Sigma-Aldrich; Merck KGaA) staining assay. Briefly, cells were incubated with DCF-DA solution (100 &#x00B5;M) at 37&#x00B0;C for 1 h, after RA and H<sub>2</sub>O<sub>2</sub> treatment. ROS levels were then analyzed using flow cytometry. The proportion of fluorescence-positive cells was measured using a FACSCalibur flow cytometer (BD Biosciences, San Diego, CA, USA) with excitation and emission filters of 488 and 530 nm, respectively. <italic>N</italic>-acetyl-cysteine (NAC), ROS scavenger used as a positive control, was purchased from Sigma-Aldrich; Merck KGaA.</p>
</sec>
<sec>
<title>NF-&#x03BA;B luciferase reporter assay</title>
<p>The NF-&#x03BA;B luciferase reporter assay was conducted as previously described (<xref rid="b27-mmr-16-06-9763" ref-type="bibr">27</xref>) with some modifications. Briefly, NF-&#x03BA;B reporter NIH3T3 cells were seeded in 12-well cell culture plates at a density of 2&#x00D7;10<sup>5</sup> cells/well. After 24 h incubation, cells were pretreated RA for 12 h at 10, 20 and 30 &#x00B5;M, and were then treated with 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 2 h. At the end of the experiments, the cells were resuspended in Passive Lysis Buffer (Promega Corporation, Madison, WI, USA). Subsequently, luciferin (Sigma-Aldrich; Merck KGaA) was added to the cells, and luciferase activity was measured using a Veritas luminometer (Turner Designs, Sunnyvale, CA, USA). The luciferase activity was normalized to &#x03B2;-galactosidase (&#x03B2;-gal) activity, and relative activity is presented as the percentage activity of the control with standard deviation. The results represent the mean of three independent experiments.</p>
</sec>
<sec>
<title>Senescence-associated &#x03B2;-gal (SA-&#x03B2;-gal) activity</title>
<p>&#x03B2;-gal expression was used as a marker of senescence (<xref rid="b28-mmr-16-06-9763" ref-type="bibr">28</xref>). &#x03B2;-gal expression levels were determined using an SA-&#x03B2;-gal staining kit (Biovision, Inc., Milpitas, CA, USA) according to the manufacturer&#x0027;s instructions. NHDFs were seeded at a density of 1&#x00D7;10<sup>6</sup> cells/well in 60-mm cell culture plates and were incubated until cell confluence reached 90&#x0025;. Later, cells were pretreated RA for 12 h at 10, 20 and 30 &#x00B5;M, and were then treated with 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 2 h. After treatment, the cells were washed in PBS and incubated in 0.5 ml fixative solution (4&#x0025; formaldehyde, 0.5&#x0025; glutaraldehyde in PBS buffer, pH 7.2) for 10 min at room temperature. The fixed cells were incubated in a staining solution mixture [staining solution (470 &#x00B5;l), staining supplement (5 &#x00B5;l) and 20 mg/ml X-Gal in dimethylformamide (25 &#x00B5;l)] for 24 h at 37&#x00B0;C. Subsequently, 70&#x0025; glycerol (1 ml) was added to the cells and blue SA-&#x03B2;-gal-positive cells were counted under a microscope (Olympus IX51; Olympus Corporation, Tokyo, Japan).</p>
</sec>
<sec>
<title>RNA isolation and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis</title>
<p>Before RNA extraction, cells were treated with RA (10, 20 and 30 &#x00B5;M) for 12 h and H<sub>2</sub>O<sub>2</sub> (600 &#x00B5;M) for 2 h, in a consecutive manner. Total RNA was extracted using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer&#x0027;s instructions. RNA purity and concentration were evaluated using a MaestroNano<sup>&#x00AE;</sup> microspectrophotometer (Maestrogen, Las Vegas, NV, USA). Total RNA was reverse transcribed into cDNA using the oiligo d(T)<sub>23</sub> primer and ProtoScript First Strand cDNA Synthesis kit (New England BioLabs, Inc., Ipswich, MA, USA) following the manufacturer&#x0027;s instructions. <italic>HO-1, SOD1, CAT, SIRT1, TNF-&#x03B1; and IL-6</italic> mRNA expression levels were evaluated using 5&#x00D7; HOT FIREPOL<sup>&#x00AE;</sup> EvaGreen<sup>&#x00AE;</sup> qPCR mix (Solis BioDyne, Tartu, Estonia), a StepOnePlus Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) and gene-specific primers. Each thermo-cycling condition was same in denaturation (95&#x00B0;C) and extension (72&#x00B0;C), except the annealing temperature which differed when different primers were used. The Cq value associated with each gene was normalized to the expression of the &#x03B2;-actin housekeeping gene. The sequences of the qPCR primers are provided in <xref rid="tI-mmr-16-06-9763" ref-type="table">Table I</xref>. The 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> method (<xref rid="b29-mmr-16-06-9763" ref-type="bibr">29</xref>) was used to calculate the relative expression levels of each gene.</p>
</sec>
<sec>
<title>Analysis of luciferase reporter gene activity</title>
<p>Transcriptional activity of NRF2 was determined using an antioxidant ARE Reporter kit (cat. no. 60514; BPS Bioscience, San Diego, CA, USA). The luciferase activity was quantitatively assessed according to the manufacturer&#x0027;s instructions. Briefly, NHDFs were cotransfected with NRF2-ARE-luciferase reporter plasmid (BPS Bioscience) and a plasmid that constitutively expressed <italic>Renilla</italic> luciferase using Lipofectamine&#x2122; 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). The transfection was conducted according to the manufacturer&#x0027;s instructions with some modifications. The Lipofectamine reagent was mixed with serum-free Opti-MEM (Invitrogen; Thermo Fisher Scientific, Inc.) for 5 min, and then added to the plasmid with gently flicking for 20 min, at room temperature. The transfection mixture was added to the cells and incubated at 37&#x00B0;C. After 24 h of transfection, cells were pretreated for 12 h with the indicated doses of RA (10, 20 and 30 &#x00B5;M), and were then exposed to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 2 h. The cells were re-suspended in Passive lysis buffer (Promega Corporation) and luciferase activity was measured using a Dual-Luciferase Reporter Assay system (Promega Corporation). The luciferase activity of ARE was normalized to <italic>Renilla</italic> luciferase activity.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All results are presented as the mean &#x00B1; standard deviation of three independent experiments. Statistical analysis was performed using SPSS software version 17.0 (SPSS, Inc., Chicago, IL, USA). One-way analysis of variance followed by Tukey post hoc test was conducted for multiple comparisons. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>RA reduces H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity in NHDFs</title>
<p>The present study initially determined the dose range of RA that was not markedly cytotoxic to NHDFs. The cells were treated with increasing concentrations of RA (0&#x2013;50 &#x00B5;M) for 12 h. Concentrations of RA &#x003C;50 &#x00B5;M were not were not significantly cytotoxic; therefore, 10&#x2013;30 &#x00B5;M RA was used for subsequent experiments. To determine if RA affects the viability of NHDFs exposed to H<sub>2</sub>O<sub>2</sub>-induced cellular stress, NHDFs were sequentially treated with RA and H<sub>2</sub>O<sub>2</sub>, and cytotoxicity was evaluated using a WST-1 assay. As presented in <xref rid="f1-mmr-16-06-9763" ref-type="fig">Fig. 1</xref>, cell viability decreased to 76&#x0025; of the control in cells treated with 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. Pretreatment with 10&#x2013;30 &#x00B5;M RA for 12 h significantly inhibited H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity (<xref rid="f1-mmr-16-06-9763" ref-type="fig">Fig. 1B</xref>).</p>
</sec>
<sec>
<title>RA inhibits H<sub>2</sub>O<sub>2</sub>-mediated induction of SA-&#x03B2;-gal activity in NHDFs</title>
<p>H<sub>2</sub>O<sub>2</sub>-mediated ROS activates endogenous cellular responses to oxidative stress (<xref rid="b30-mmr-16-06-9763" ref-type="bibr">30</xref>). However, when this defense system collapses, superoxide anion, hydroxyl radical and singlet oxygen production induces cellular senescence and apoptosis (<xref rid="b31-mmr-16-06-9763" ref-type="bibr">31</xref>&#x2013;<xref rid="b33-mmr-16-06-9763" ref-type="bibr">33</xref>). In the present study, H<sub>2</sub>O<sub>2</sub> induced cellular senescence in NHDFs, as demonstrated by an SA-&#x03B2;-gal assay (<xref rid="f2-mmr-16-06-9763" ref-type="fig">Fig. 2</xref>). Notably, RA markedly inhibited cellular senescence in a concentration-dependent manner in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs (<xref rid="f2-mmr-16-06-9763" ref-type="fig">Fig. 2</xref>), thus suggesting that RA protects NHDFs from H<sub>2</sub>O<sub>2</sub>-mediated induction of SA-&#x03B2;-gal activity.</p>
</sec>
<sec>
<title>RA inhibits H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in NHDFs</title>
<p>Similar to previous studies, the present study investigated whether the protective effects of RA were associated with its oxidative properties (<xref rid="b23-mmr-16-06-9763" ref-type="bibr">23</xref>&#x2013;<xref rid="b25-mmr-16-06-9763" ref-type="bibr">25</xref>). To evaluate the ROS scavenging activity of RA, H<sub>2</sub>O<sub>2</sub> scavenging activity, DCF-DA fluorescence intensity, NRF2 activity and the expression of genes that regulate oxidative stress (<italic>HO-1</italic>, <italic>SOD1</italic> and <italic>CAT</italic>) were assessed. RA showed an increase in H<sub>2</sub>O<sub>2</sub> scavenging activity and ascorbic acid was used as positive control (<xref rid="f3-mmr-16-06-9763" ref-type="fig">Fig. 3A</xref>). Although the free radical scavenging activity of RA was less than the positive control (L-ascorbic acid), the half maximal inhibitory concentration of RA was 0.56 mg/ml, and the radical scavenging activity of RA occurred in a dose-dependent manner. DCF fluorescence intensity, which is an indicator of intracellular ROS levels, was evaluated in RA-pretreated NHDFs with or without H<sub>2</sub>O<sub>2</sub> exposure. DCF intensity increased &#x003E;8-fold in H<sub>2</sub>O<sub>2</sub>-exposed cells compared with the nonexposed control group (<xref rid="f2-mmr-16-06-9763" ref-type="fig">Fig. 2B</xref>). However, this effect was strongly reduced in NHDFs pretreated with either RA or the positive control antioxidant NAC (<xref rid="f3-mmr-16-06-9763" ref-type="fig">Fig. 3B</xref>). NRF2 serves a key role in the regulation of antioxidant mechanisms by activating the transcription of genes encoding antioxidant enzymes, including <italic>HO-1</italic>, <italic>SOD1</italic> and <italic>CAT</italic>, via the ARE in the target gene promoter (<xref rid="b5-mmr-16-06-9763" ref-type="bibr">5</xref>&#x2013;<xref rid="b7-mmr-16-06-9763" ref-type="bibr">7</xref>). Therefore, the present study analyzed the transcriptional activity of NRF2 using the ARE-luciferase assay. As presented in <xref rid="f3-mmr-16-06-9763" ref-type="fig">Fig. 3C</xref>, RA markedly enhanced luciferase activity in a concentration-dependent manner, thus suggesting that RA activates NRF2 activity in NHDFs. In addition, the expression levels of the NRF2 target genes, <italic>HO-1</italic>, <italic>SOD1</italic> and <italic>CAT</italic>, were detected. Notably, RA markedly upregulated the target genes against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress (<xref rid="f3-mmr-16-06-9763" ref-type="fig">Fig. 3D</xref>). These results suggested that RA exerts a protective effect on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in NHDFs via NRF2-associated antioxidant mechanisms.</p>
</sec>
<sec>
<title>RA inhibits the H<sub>2</sub>O<sub>2</sub>-induced inflammatory response in NHDFs</title>
<p>The mammalian Sir2 ortholog, SIRT1, is a histone deacetylase that targets histones and nonhistone substrates, including NF-&#x03BA;B and p53 (<xref rid="b8-mmr-16-06-9763" ref-type="bibr">8</xref>,<xref rid="b9-mmr-16-06-9763" ref-type="bibr">9</xref>,<xref rid="b34-mmr-16-06-9763" ref-type="bibr">34</xref>). Previous studies have demonstrated that SIRT1 is involved in the regulation of numerous cellular processes, including inflammation, apoptosis and autophagy, and that SIRT1 expression is downregulated in response to oxidative stress (<xref rid="b10-mmr-16-06-9763" ref-type="bibr">10</xref>&#x2013;<xref rid="b12-mmr-16-06-9763" ref-type="bibr">12</xref>,<xref rid="b35-mmr-16-06-9763" ref-type="bibr">35</xref>). Therefore, the present study evaluated the expression levels of SIRT1 and various inflammatory cytokines, including NF-&#x03BA;B, TNF-&#x03B1; and IL-6 in NHDFs. <italic>SIRT1</italic> levels were decreased in NHDFs exposed to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, whereas RA inhibited this effect in a concentration-dependent manner (<xref rid="f4-mmr-16-06-9763" ref-type="fig">Fig. 4A</xref>). To determine the effects of H<sub>2</sub>O<sub>2</sub> and RA on NF-&#x03BA;B expression, an NF-&#x03BA;B luciferase reporter stable NIH-3T3 cell line was used. As presented in <xref rid="f4-mmr-16-06-9763" ref-type="fig">Fig. 4B</xref>, relative luciferase activity in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs increased 5.71&#x00B1;0.42-fold compared with the control group (P&#x003C;0.05). Notably, pretreatment with 20 and 30 &#x00B5;M RA significantly inhibited this effect (P&#x003C;0.05). To further evaluate the effects of H<sub>2</sub>O<sub>2</sub> and RA on the activity of NF-&#x03BA;B, the expression levels of the NF-&#x03BA;B target genes, <italic>TNF-&#x03B1;</italic> and <italic>IL-6</italic>, were determined. H<sub>2</sub>O<sub>2</sub> upregulated <italic>TNF-&#x03B1;</italic> and <italic>IL</italic>-6 expression, whereas RA significantly inhibited this effect in a concentration-dependent manner (<xref rid="f4-mmr-16-06-9763" ref-type="fig">Fig. 4C</xref>). Taken together, these results indicated that RA exerts an anti-inflammatory effect on NHDFs under conditions of excessive oxidative stress.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Numerous studies have demonstrated that ROS exist in all living tissues, and are essential for various cellular functions, including epithelial cell proliferation and wound healing (<xref rid="b36-mmr-16-06-9763" ref-type="bibr">36</xref>), and dermal fibroblast migration (<xref rid="b37-mmr-16-06-9763" ref-type="bibr">37</xref>). However, excess ROS can trigger deleterious effects, such as apoptosis and cellular senescence (<xref rid="b3-mmr-16-06-9763" ref-type="bibr">3</xref>). There is a marked decreased in antioxidant levels in aged skin, and treating aged skin with antioxidants, such as resveratrol and vitamin E, can partially rejuvenate aged skin (<xref rid="b38-mmr-16-06-9763" ref-type="bibr">38</xref>). These findings suggested that ROS may be the primary cause for the appearance of aging skin. H<sub>2</sub>O<sub>2</sub> is a type of ROS, which is generated in response to UV light and numerous pollutants (<xref rid="b39-mmr-16-06-9763" ref-type="bibr">39</xref>). The histological alterations in aged skin are markedly visible in the dermis layer, where dermal fibroblasts are the primary cell type (<xref rid="b40-mmr-16-06-9763" ref-type="bibr">40</xref>). In addition, a reduction in CAT activity and an increase in H<sub>2</sub>O<sub>2</sub> levels have been observed in dermal fibroblasts from aged human skin compared with in dermal fibroblasts from younger human skin (<xref rid="b41-mmr-16-06-9763" ref-type="bibr">41</xref>). In a previous study, treatment with exogenous CAT rescued the reduction in intracellular CAT protein activity and the increase in H<sub>2</sub>O<sub>2</sub> levels in aged fibroblasts, and also reduced collagenase matrix metalloproteinase 1 expression (<xref rid="b41-mmr-16-06-9763" ref-type="bibr">41</xref>). These data indicated that suppressing H<sub>2</sub>O<sub>2</sub> generation in dermal fibroblasts may inhibit the skin aging process. Notably, in the present study, H<sub>2</sub>O<sub>2</sub> exposure strongly enhanced cytotoxicity and SA-&#x03B2;-gal activity, which are similar to the effects observed in tissues from older individuals (<xref rid="b42-mmr-16-06-9763" ref-type="bibr">42</xref>). However, RA pretreatment markedly protected NHDFs from H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity and SA-&#x03B2;-gal activation. In addition, the H<sub>2</sub>O<sub>2</sub> scavenging capacity of RA was investigated, as was the intracellular H<sub>2</sub>O<sub>2</sub> scavenging capacity of RA in NHDFs. The results demonstrated that RA exhibited substantial H<sub>2</sub>O<sub>2</sub> scavenging activity and inhibited H<sub>2</sub>O<sub>2</sub>-induced intracellular ROS production. Taken together, these data suggested that RA may be considered a potential ingredient in anti-aging skin products.</p>
<p>The results of the present study prompted the hypothesis that RA may regulate intracellular antioxidant activity in NHDFs. Although RA has exhibited antioxidant activity in keratinocytes (<xref rid="b24-mmr-16-06-9763" ref-type="bibr">24</xref>,<xref rid="b25-mmr-16-06-9763" ref-type="bibr">25</xref>), there are differences in the oxidative stress response between keratinocytes and dermal fibroblasts (<xref rid="b43-mmr-16-06-9763" ref-type="bibr">43</xref>). To test the hypothesis, ARE luciferase assays and RT-qPCR were conducted to evaluate the expression of the antioxidant-induced NRF2 target genes <italic>HO-1</italic>, <italic>SOD1</italic> and <italic>CAT</italic>. RA rescued H<sub>2</sub>O<sub>2</sub>-mediated inhibition of NRF2 transcriptional activity and the consequential decrease in NRF2 target gene expression. Consistent with these findings, a previous study demonstrated that RA inhibits UVB-induced ROS production and the decrease in protein levels encoded by NRF2 target genes in HaCaT keratinocytes (<xref rid="b24-mmr-16-06-9763" ref-type="bibr">24</xref>). In addition, a previous report demonstrated that the NRF2-inducer tanshinone I exerted a protective effect against UV radiation in human skin cells and reconstructed human skin (<xref rid="b44-mmr-16-06-9763" ref-type="bibr">44</xref>). Furthermore, <italic>NRF2</italic> depletion induces damage to the extracellular matrix (<xref rid="b45-mmr-16-06-9763" ref-type="bibr">45</xref>), a hallmark of skin aging (<xref rid="b46-mmr-16-06-9763" ref-type="bibr">46</xref>). Taken together, these findings indicated that RA may inhibit H<sub>2</sub>O<sub>2</sub> via a NRF2-associated antioxidant mechanism in NHDFs.</p>
<p>The present study also demonstrated that RA inhibited the H<sub>2</sub>O<sub>2</sub>-induced inflammatory response in NHDFs. Oxidative stress is associated with inflammation in skin tissue (<xref rid="b47-mmr-16-06-9763" ref-type="bibr">47</xref>), and upregulation of the inflammatory response is associated with numerous skin diseases, including atopic dermatitis and psoriasis (<xref rid="b48-mmr-16-06-9763" ref-type="bibr">48</xref>). SIRT1 serves critical roles in apoptosis, senescence, autophagy, gene silencing and inflammation (<xref rid="b11-mmr-16-06-9763" ref-type="bibr">11</xref>,<xref rid="b12-mmr-16-06-9763" ref-type="bibr">12</xref>,<xref rid="b48-mmr-16-06-9763" ref-type="bibr">48</xref>,<xref rid="b49-mmr-16-06-9763" ref-type="bibr">49</xref>). Under excessive ROS conditions, SIRT1 is inactivated and cannot suppress the activity of NF-&#x03BA;B, which is a protein that serves a key role in inflammatory responses by activating the transcription of proinflammatory cytokines, such as TNF-&#x03B1; and IL-6 (<xref rid="b16-mmr-16-06-9763" ref-type="bibr">16</xref>). In the present study, RA inhibited H<sub>2</sub>O<sub>2</sub>-mediated <italic>SIRT1</italic> downregulation in NHDFs, and NF-&#x03BA;B activity was decreased in RA-treated NHDFs. Furthermore, RA significantly downregulated the expression levels of <italic>TNF-&#x03B1;</italic> and <italic>IL-6</italic> in a dose-dependent manner. NF-&#x03BA;B activation is regarded as a potential biomarker of aging (<xref rid="b14-mmr-16-06-9763" ref-type="bibr">14</xref>); an increase in NF-&#x03BA;B activity is correlated with tissue aging and age-associated degenerative diseases (<xref rid="b15-mmr-16-06-9763" ref-type="bibr">15</xref>).</p>
<p>In conclusion, the findings of the present study suggested that RA may inhibit senescence and inflammatory responses in NHDFs, which are effects associated with aging skin. To gain insight into the effects of RA on human skin, further studies should focus on the efficacy of RA in reversing the signs of aging skin and evaluate the precise molecular mechanisms by which RA mediates this effect <italic>in vivo</italic>.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by a grant from the Ministry of Trade, Industry and Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region (grant no. R0003962) and a grant from the Marine Biotechnology Program (grant no. 20150184) funded by the Ministry of Oceans and Fishers, Republic of Korea.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-16-06-9763"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poljsak</surname><given-names>B</given-names></name><name><surname>Dahmane</surname><given-names>RG</given-names></name><name><surname>Godi&#x0107;</surname><given-names>A</given-names></name></person-group><article-title>Intrinsic skin aging: The role of oxidative stress</article-title><source>Acta Dermatovenerol Alp Pannonica Adriat</source><volume>21</volume><fpage>33</fpage><lpage>36</lpage><year>2012</year><pub-id pub-id-type="pmid">23000938</pub-id></element-citation></ref>
<ref id="b2-mmr-16-06-9763"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganceviciene</surname><given-names>R</given-names></name><name><surname>Liakou</surname><given-names>AI</given-names></name><name><surname>Theodoridis</surname><given-names>A</given-names></name><name><surname>Makrantonaki</surname><given-names>E</given-names></name><name><surname>Zouboulis</surname><given-names>CC</given-names></name></person-group><article-title>Skin anti-aging strategies</article-title><source>Dermatoendocrinol</source><volume>4</volume><fpage>308</fpage><lpage>319</lpage><year>2012</year><pub-id pub-id-type="doi">10.4161/derm.22804</pub-id><pub-id pub-id-type="pmid">23467476</pub-id><pub-id pub-id-type="pmcid">3583892</pub-id></element-citation></ref>
<ref id="b3-mmr-16-06-9763"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davalli</surname><given-names>P</given-names></name><name><surname>Mitic</surname><given-names>T</given-names></name><name><surname>Caporali</surname><given-names>A</given-names></name><name><surname>Lauriola</surname><given-names>A</given-names></name><name><surname>D&#x0027;Arca</surname><given-names>D</given-names></name></person-group><article-title>ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases</article-title><source>Oxid Med Cell Longev</source><volume>2016</volume><fpage>3565127</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/3565127</pub-id><pub-id pub-id-type="pmid">27247702</pub-id><pub-id pub-id-type="pmcid">4877482</pub-id></element-citation></ref>
<ref id="b4-mmr-16-06-9763"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kansanen</surname><given-names>E</given-names></name><name><surname>Kuosmanen</surname><given-names>SM</given-names></name><name><surname>Leinonen</surname><given-names>H</given-names></name><name><surname>Levonen</surname><given-names>AL</given-names></name></person-group><article-title>The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer</article-title><source>Redox Biol</source><volume>1</volume><fpage>45</fpage><lpage>49</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.redox.2012.10.001</pub-id><pub-id pub-id-type="pmid">24024136</pub-id><pub-id pub-id-type="pmcid">3757665</pub-id></element-citation></ref>
<ref id="b5-mmr-16-06-9763"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kensler</surname><given-names>TW</given-names></name><name><surname>Wakabayashi</surname><given-names>N</given-names></name><name><surname>Biswal</surname><given-names>S</given-names></name></person-group><article-title>Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway</article-title><source>Annu Rev Pharmacol Toxicol</source><volume>47</volume><fpage>89</fpage><lpage>116</lpage><year>2007</year><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.46.120604.141046</pub-id><pub-id pub-id-type="pmid">16968214</pub-id></element-citation></ref>
<ref id="b6-mmr-16-06-9763"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Katoh</surname><given-names>Y</given-names></name><name><surname>Oyake</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>N</given-names></name><name><surname>Satoh</surname><given-names>K</given-names></name><name><surname>Hatayama</surname><given-names>I</given-names></name><etal/></person-group><article-title>An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</article-title><source>Biochem Biophys Res Commun</source><volume>236</volume><fpage>313</fpage><lpage>322</lpage><year>1997</year><pub-id pub-id-type="doi">10.1006/bbrc.1997.6943</pub-id><pub-id pub-id-type="pmid">9240432</pub-id></element-citation></ref>
<ref id="b7-mmr-16-06-9763"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buendia</surname><given-names>I</given-names></name><name><surname>Michalska</surname><given-names>P</given-names></name><name><surname>Navarro</surname><given-names>E</given-names></name><name><surname>Gameiro</surname><given-names>I</given-names></name><name><surname>Egea</surname><given-names>J</given-names></name><name><surname>Leon</surname><given-names>R</given-names></name></person-group><article-title>Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases</article-title><source>Pharmacol Ther</source><volume>157</volume><fpage>84</fpage><lpage>104</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.11.003</pub-id><pub-id pub-id-type="pmid">26617217</pub-id></element-citation></ref>
<ref id="b8-mmr-16-06-9763"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Nikolaev</surname><given-names>AY</given-names></name><name><surname>Imai</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Su</surname><given-names>F</given-names></name><name><surname>Shiloh</surname><given-names>A</given-names></name><name><surname>Guarente</surname><given-names>L</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name></person-group><article-title>Negative control of p53 by Sir2alpha promotes cell survival under stress</article-title><source>Cell</source><volume>107</volume><fpage>137</fpage><lpage>148</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00524-4</pub-id><pub-id pub-id-type="pmid">11672522</pub-id></element-citation></ref>
<ref id="b9-mmr-16-06-9763"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaziri</surname><given-names>H</given-names></name><name><surname>Dessain</surname><given-names>SK</given-names></name><name><surname>Ng Eaton</surname><given-names>E</given-names></name><name><surname>Imai</surname><given-names>SI</given-names></name><name><surname>Frye</surname><given-names>RA</given-names></name><name><surname>Pandita</surname><given-names>TK</given-names></name><name><surname>Guarente</surname><given-names>L</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase</article-title><source>Cell</source><volume>107</volume><fpage>149</fpage><lpage>159</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00527-X</pub-id><pub-id pub-id-type="pmid">11672523</pub-id></element-citation></ref>
<ref id="b10-mmr-16-06-9763"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Gomez-Pinilla</surname><given-names>F</given-names></name></person-group><article-title>Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex</article-title><source>Eur J Neurosci</source><volume>23</volume><fpage>2573</fpage><lpage>2580</lpage><year>2006</year><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04807.x</pub-id><pub-id pub-id-type="pmid">16817860</pub-id></element-citation></ref>
<ref id="b11-mmr-16-06-9763"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>MH</given-names></name><name><surname>Jeong</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Seol</surname><given-names>JW</given-names></name><name><surname>Jackson</surname><given-names>CJ</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name></person-group><article-title>SIRT1, a class III histone deacetylase, regulates TNF-&#x03B1;-induced inflammation in human chondrocytes</article-title><source>Osteoarthritis Cartilage</source><volume>21</volume><fpage>470</fpage><lpage>480</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.joca.2012.11.017</pub-id><pub-id pub-id-type="pmid">23257246</pub-id></element-citation></ref>
<ref id="b12-mmr-16-06-9763"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayama</surname><given-names>K</given-names></name><name><surname>Ishida</surname><given-names>K</given-names></name><name><surname>Matsushita</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Tei</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Fujioka</surname><given-names>H</given-names></name></person-group><article-title>SIRT1 regulation of apoptosis of human chondrocytes</article-title><source>Arthritis Rheum</source><volume>60</volume><fpage>2731</fpage><lpage>2740</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/art.24864</pub-id><pub-id pub-id-type="pmid">19714620</pub-id></element-citation></ref>
<ref id="b13-mmr-16-06-9763"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salminen</surname><given-names>A</given-names></name><name><surname>Kauppinen</surname><given-names>A</given-names></name><name><surname>Suuronen</surname><given-names>T</given-names></name><name><surname>Kaarniranta</surname><given-names>K</given-names></name></person-group><article-title>SIRT1 longevity factor suppresses NF-kappaB-driven immune responses: Regulation of aging via NF-kappaB acetylation?</article-title><source>Bioessays</source><volume>30</volume><fpage>939</fpage><lpage>942</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/bies.20799</pub-id><pub-id pub-id-type="pmid">18800364</pub-id></element-citation></ref>
<ref id="b14-mmr-16-06-9763"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balistreri</surname><given-names>CR</given-names></name><name><surname>Candore</surname><given-names>G</given-names></name><name><surname>Accardi</surname><given-names>G</given-names></name><name><surname>Colonna-Romano</surname><given-names>G</given-names></name><name><surname>Lio</surname><given-names>D</given-names></name></person-group><article-title>NF-&#x03BA;B pathway activators as potential ageing biomarkers: Targets for new therapeutic strategies</article-title><source>Immun Ageing</source><volume>10</volume><fpage>24</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1742-4933-10-24</pub-id><pub-id pub-id-type="pmid">23786653</pub-id><pub-id pub-id-type="pmcid">3695812</pub-id></element-citation></ref>
<ref id="b15-mmr-16-06-9763"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilstra</surname><given-names>JS</given-names></name><name><surname>Clauson</surname><given-names>CL</given-names></name><name><surname>Niedernhofer</surname><given-names>LJ</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name></person-group><article-title>NF-&#x03BA;B in Aging and Disease</article-title><source>Aging Dis</source><volume>2</volume><fpage>449</fpage><lpage>465</lpage><year>2011</year><pub-id pub-id-type="pmid">22396894</pub-id><pub-id pub-id-type="pmcid">3295063</pub-id></element-citation></ref>
<ref id="b16-mmr-16-06-9763"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tak</surname><given-names>PP</given-names></name><name><surname>Firestein</surname><given-names>GS</given-names></name></person-group><article-title>NF-kappaB: A key role in inflammatory diseases</article-title><source>J Clin Invest</source><volume>107</volume><fpage>7</fpage><lpage>11</lpage><year>2001</year><pub-id pub-id-type="doi">10.1172/JCI11830</pub-id><pub-id pub-id-type="pmid">11134171</pub-id><pub-id pub-id-type="pmcid">198552</pub-id></element-citation></ref>
<ref id="b17-mmr-16-06-9763"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vladimir-Knezevic</surname><given-names>S</given-names></name><name><surname>Blazekovic</surname><given-names>B</given-names></name><name><surname>Kindl</surname><given-names>M</given-names></name><name><surname>Vladic</surname><given-names>J</given-names></name><name><surname>Lower-Nedza</surname><given-names>AD</given-names></name><name><surname>Brantner</surname><given-names>AH</given-names></name></person-group><article-title>Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family</article-title><source>Molecules</source><volume>19</volume><fpage>767</fpage><lpage>782</lpage><year>2014</year><pub-id pub-id-type="doi">10.3390/molecules19010767</pub-id><pub-id pub-id-type="pmid">24413832</pub-id></element-citation></ref>
<ref id="b18-mmr-16-06-9763"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>AH</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Kim</surname><given-names>GD</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Jin</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name></person-group><article-title>Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice</article-title><source>Int Immunopharmacol</source><volume>11</volume><fpage>1271</fpage><lpage>1277</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.intimp.2011.04.007</pub-id><pub-id pub-id-type="pmid">21504802</pub-id></element-citation></ref>
<ref id="b19-mmr-16-06-9763"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karthik</surname><given-names>D</given-names></name><name><surname>Viswanathan</surname><given-names>P</given-names></name><name><surname>Anuradha</surname><given-names>CV</given-names></name></person-group><article-title>Administration of rosmarinic acid reduces cardiopathology and blood pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats</article-title><source>J Cardiovasc Pharmacol</source><volume>58</volume><fpage>514</fpage><lpage>521</lpage><year>2011</year><pub-id pub-id-type="doi">10.1097/FJC.0b013e31822c265d</pub-id><pub-id pub-id-type="pmid">21795992</pub-id></element-citation></ref>
<ref id="b20-mmr-16-06-9763"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>GD</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Jin</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name></person-group><article-title>Production and applications of rosmarinic acid and structurally related compounds</article-title><source>Appl Microbiol Biotechnol</source><volume>99</volume><fpage>2083</fpage><lpage>2092</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s00253-015-6395-6</pub-id><pub-id pub-id-type="pmid">25620368</pub-id></element-citation></ref>
<ref id="b21-mmr-16-06-9763"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khojasteh</surname><given-names>A</given-names></name><name><surname>Mirjalili</surname><given-names>MH</given-names></name><name><surname>Hidalgo</surname><given-names>D</given-names></name><name><surname>Corchete</surname><given-names>P</given-names></name><name><surname>Palazon</surname><given-names>J</given-names></name></person-group><article-title>New trends in biotechnological production of rosmarinic acid</article-title><source>Biotechnol Lett</source><volume>36</volume><fpage>2393</fpage><lpage>2406</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10529-014-1640-0</pub-id><pub-id pub-id-type="pmid">25214214</pub-id></element-citation></ref>
<ref id="b22-mmr-16-06-9763"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Campillo</surname><given-names>M</given-names></name><name><surname>Gabaldon</surname><given-names>JA</given-names></name><name><surname>Castillo</surname><given-names>J</given-names></name><name><surname>Benavente-Garc&#x00ED;a</surname><given-names>O</given-names></name><name><surname>Del Ba&#x00F1;o</surname><given-names>MJ</given-names></name><name><surname>Alcaraz</surname><given-names>M</given-names></name><name><surname>Vicente</surname><given-names>V</given-names></name><name><surname>Alvarez</surname><given-names>N</given-names></name><name><surname>Lozano</surname><given-names>JA</given-names></name></person-group><article-title>Rosmarinic acid, a photo-protective agent against UV and other ionizing radiations</article-title><source>Food Chem Toxicol</source><volume>47</volume><fpage>386</fpage><lpage>392</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.fct.2008.11.026</pub-id><pub-id pub-id-type="pmid">19084569</pub-id></element-citation></ref>
<ref id="b23-mmr-16-06-9763"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>SM</given-names></name><name><surname>Kang</surname><given-names>JR</given-names></name></person-group><article-title>Antioxidation effects of rosmarinic acid on human skin melanoma cells treated with hydrogen peroxide</article-title><source>J Korean Soc Appl Bi</source><volume>52</volume><fpage>247</fpage><lpage>251</lpage><year>2009</year><pub-id pub-id-type="doi">10.3839/jksabc.2009.044</pub-id></element-citation></ref>
<ref id="b24-mmr-16-06-9763"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernando</surname><given-names>PM</given-names></name><name><surname>Piao</surname><given-names>MJ</given-names></name><name><surname>Kang</surname><given-names>KA</given-names></name><name><surname>Ryu</surname><given-names>YS</given-names></name><name><surname>Hewage</surname><given-names>SR</given-names></name><name><surname>Chae</surname><given-names>SW</given-names></name><name><surname>Hyun</surname><given-names>JW</given-names></name></person-group><article-title>Rosmarinic acid attenuates cell damage against UVB radiation-induced oxidative stress via enhancing antioxidant effects in human HaCaT cells</article-title><source>Biomol Ther (Seoul)</source><volume>24</volume><fpage>75</fpage><lpage>84</lpage><year>2016</year><pub-id pub-id-type="doi">10.4062/biomolther.2015.069</pub-id><pub-id pub-id-type="pmid">26759705</pub-id><pub-id pub-id-type="pmcid">4703356</pub-id></element-citation></ref>
<ref id="b25-mmr-16-06-9763"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vost&#x00E1;lov&#x00E1;</surname><given-names>J</given-names></name><name><surname>Zdarilov&#x00E1;</surname><given-names>A</given-names></name><name><surname>Svobodov&#x00E1;</surname><given-names>A</given-names></name></person-group><article-title>Prunella vulgaris extract and rosmarinic acid prevent UVB-induced DNA damage and oxidative stress in HaCaT keratinocytes</article-title><source>Arch Dermatol Res</source><volume>302</volume><fpage>171</fpage><lpage>181</lpage><year>2010</year><pub-id pub-id-type="doi">10.1007/s00403-009-0999-6</pub-id><pub-id pub-id-type="pmid">19862537</pub-id></element-citation></ref>
<ref id="b26-mmr-16-06-9763"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyedemi</surname><given-names>SO</given-names></name><name><surname>Bradley</surname><given-names>G</given-names></name><name><surname>Afolayan</surname><given-names>AJ</given-names></name></person-group><article-title>In-vitro and -vivo antioxidant activities of aqueous extract of Strychnos henningsii Gilg</article-title><source>Afr J Pharm Pharmaco</source><volume>4</volume><fpage>70</fpage><lpage>78</lpage><year>2010</year></element-citation></ref>
<ref id="b27-mmr-16-06-9763"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Outschoorn</surname><given-names>UE</given-names></name><name><surname>Trimmer</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Whitaker-Menezes</surname><given-names>D</given-names></name><name><surname>Chiavarina</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Pavlides</surname><given-names>S</given-names></name><name><surname>Martinez-Cantarin</surname><given-names>MP</given-names></name><name><surname>Capozza</surname><given-names>F</given-names></name><etal/></person-group><article-title>Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NF&#x03BA;B activation in the tumor stromal microenvironment</article-title><source>Cell Cycle</source><volume>9</volume><fpage>3515</fpage><lpage>3533</lpage><year>2010</year><pub-id pub-id-type="doi">10.4161/cc.9.17.12928</pub-id><pub-id pub-id-type="pmid">20855962</pub-id><pub-id pub-id-type="pmcid">3047617</pub-id></element-citation></ref>
<ref id="b28-mmr-16-06-9763"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debacq-Chainiaux</surname><given-names>F</given-names></name><name><surname>Erusalimsky</surname><given-names>JD</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name><name><surname>Toussaint</surname><given-names>O</given-names></name></person-group><article-title>Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo</article-title><source>Nat Protoc</source><volume>4</volume><fpage>1798</fpage><lpage>1806</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/nprot.2009.191</pub-id><pub-id pub-id-type="pmid">20010931</pub-id></element-citation></ref>
<ref id="b29-mmr-16-06-9763"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b30-mmr-16-06-9763"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martindale</surname><given-names>JL</given-names></name><name><surname>Holbrook</surname><given-names>NJ</given-names></name></person-group><article-title>Cellular response to oxidative stress: Signaling for suicide and survival</article-title><source>J Cell Physiol</source><volume>192</volume><fpage>1</fpage><lpage>15</lpage><year>2002</year><pub-id pub-id-type="doi">10.1002/jcp.10119</pub-id><pub-id pub-id-type="pmid">12115731</pub-id></element-citation></ref>
<ref id="b31-mmr-16-06-9763"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korycka-Dahl</surname><given-names>MB</given-names></name><name><surname>Richardson</surname><given-names>T</given-names></name></person-group><article-title>Activated oxygen species and oxidation of food constituents</article-title><source>CRC Crit Rev Food Sci Nutr</source><volume>10</volume><fpage>209</fpage><lpage>241</lpage><year>1978</year><pub-id pub-id-type="doi">10.1080/10408397809527250</pub-id><pub-id pub-id-type="pmid">215383</pub-id></element-citation></ref>
<ref id="b32-mmr-16-06-9763"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B</given-names></name><name><surname>Gutteridge</surname><given-names>JM</given-names></name></person-group><article-title>Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts</article-title><source>Arch Biochem Biophys</source><volume>246</volume><fpage>501</fpage><lpage>514</lpage><year>1986</year><pub-id pub-id-type="doi">10.1016/0003-9861(86)90305-X</pub-id><pub-id pub-id-type="pmid">3010861</pub-id></element-citation></ref>
<ref id="b33-mmr-16-06-9763"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>HU</given-names></name><name><surname>Haj-Yehia</surname><given-names>A</given-names></name><name><surname>Levi-Schaffer</surname><given-names>F</given-names></name></person-group><article-title>Role of reactive oxygen species (ROS) in apoptosis induction</article-title><source>Apoptosis</source><volume>5</volume><fpage>415</fpage><lpage>418</lpage><year>2000</year><pub-id pub-id-type="doi">10.1023/A:1009616228304</pub-id><pub-id pub-id-type="pmid">11256882</pub-id></element-citation></ref>
<ref id="b34-mmr-16-06-9763"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>F</given-names></name><name><surname>Hoberg</surname><given-names>JE</given-names></name><name><surname>Ramsey</surname><given-names>CS</given-names></name><name><surname>Keller</surname><given-names>MD</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Frye</surname><given-names>RA</given-names></name><name><surname>Mayo</surname><given-names>MW</given-names></name></person-group><article-title>Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase</article-title><source>EMBO J</source><volume>23</volume><fpage>2369</fpage><lpage>2380</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/sj.emboj.7600244</pub-id><pub-id pub-id-type="pmid">15152190</pub-id><pub-id pub-id-type="pmcid">423286</pub-id></element-citation></ref>
<ref id="b35-mmr-16-06-9763"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>MR</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Messina-Graham</surname><given-names>S</given-names></name><name><surname>Broxmeyer</surname><given-names>HE</given-names></name></person-group><article-title>SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress</article-title><source>Stem Cells</source><volume>32</volume><fpage>1183</fpage><lpage>1194</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/stem.1641</pub-id><pub-id pub-id-type="pmid">24449278</pub-id><pub-id pub-id-type="pmcid">3991763</pub-id></element-citation></ref>
<ref id="b36-mmr-16-06-9763"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>WY</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Yao</surname><given-names>YF</given-names></name><name><surname>Xing</surname><given-names>K</given-names></name><name><surname>Lou</surname><given-names>MF</given-names></name></person-group><article-title>Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing</article-title><source>Exp Eye Res</source><volume>89</volume><fpage>876</fpage><lpage>886</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.exer.2009.07.012</pub-id><pub-id pub-id-type="pmid">19635476</pub-id></element-citation></ref>
<ref id="b37-mmr-16-06-9763"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>HX</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>JJ</given-names></name><name><surname>Cai</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><etal/></person-group><article-title>bFGF promotes the migration of human dermal fibroblasts under diabetic conditions through reactive oxygen species production via the PI3K/Akt-Rac1-JNK pathways</article-title><source>Int J Biol Sci</source><volume>11</volume><fpage>845</fpage><lpage>859</lpage><year>2015</year><pub-id pub-id-type="doi">10.7150/ijbs.11921</pub-id><pub-id pub-id-type="pmid">26078726</pub-id><pub-id pub-id-type="pmcid">4466465</pub-id></element-citation></ref>
<ref id="b38-mmr-16-06-9763"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farris</surname><given-names>P</given-names></name><name><surname>Yatskayer</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Krol</surname><given-names>Y</given-names></name><name><surname>Oresajo</surname><given-names>C</given-names></name></person-group><article-title>Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin e for treatment of mild to moderately photodamaged skin</article-title><source>J Drugs Dermatol</source><volume>13</volume><fpage>1467</fpage><lpage>1472</lpage><year>2014</year><pub-id pub-id-type="pmid">25607790</pub-id></element-citation></ref>
<ref id="b39-mmr-16-06-9763"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peus</surname><given-names>D</given-names></name><name><surname>Vasa</surname><given-names>RA</given-names></name><name><surname>Meves</surname><given-names>A</given-names></name><name><surname>Pott</surname><given-names>M</given-names></name><name><surname>Beyerle</surname><given-names>A</given-names></name><name><surname>Squillace</surname><given-names>K</given-names></name><name><surname>Pittelkow</surname><given-names>MR</given-names></name></person-group><article-title>H<sub>2</sub>O<sub>2</sub> is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes</article-title><source>J Invest Dermatol</source><volume>110</volume><fpage>966</fpage><lpage>971</lpage><year>1998</year><pub-id pub-id-type="doi">10.1046/j.1523-1747.1998.00210.x</pub-id><pub-id pub-id-type="pmid">9620307</pub-id></element-citation></ref>
<ref id="b40-mmr-16-06-9763"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrest</surname><given-names>BA</given-names></name></person-group><article-title>Skin aging and photoaging: An overview</article-title><source>J Am Acad Dermatol</source><volume>21</volume><fpage>610</fpage><lpage>613</lpage><year>1989</year><pub-id pub-id-type="doi">10.1016/S0190-9622(89)70227-9</pub-id><pub-id pub-id-type="pmid">2476468</pub-id></element-citation></ref>
<ref id="b41-mmr-16-06-9763"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>MH</given-names></name><name><surname>Rhie</surname><given-names>GE</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Park</surname><given-names>CH</given-names></name><name><surname>Cho</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Eun</surname><given-names>HC</given-names></name><name><surname>Chung</surname><given-names>JH</given-names></name></person-group><article-title>H<sub>2</sub>O<sub>2</sub> accumulation by catalase reduction changes MAP kinase signaling in aged human skin in vivo</article-title><source>J Invest Dermatol</source><volume>125</volume><fpage>221</fpage><lpage>229</lpage><year>2005</year><pub-id pub-id-type="doi">10.1111/j.0022-202X.2005.23823.x</pub-id><pub-id pub-id-type="pmid">16098030</pub-id></element-citation></ref>
<ref id="b42-mmr-16-06-9763"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BY</given-names></name><name><surname>Han</surname><given-names>JA</given-names></name><name><surname>Im</surname><given-names>JS</given-names></name><name><surname>Morrone</surname><given-names>A</given-names></name><name><surname>Johung</surname><given-names>K</given-names></name><name><surname>Goodwin</surname><given-names>EC</given-names></name><name><surname>Kleijer</surname><given-names>WJ</given-names></name><name><surname>DiMaio</surname><given-names>D</given-names></name><name><surname>Hwang</surname><given-names>ES</given-names></name></person-group><article-title>Senescence-associated beta-galactosidase is lysosomal beta-galactosidase</article-title><source>Aging Cell</source><volume>5</volume><fpage>187</fpage><lpage>195</lpage><year>2006</year><pub-id pub-id-type="doi">10.1111/j.1474-9726.2006.00199.x</pub-id><pub-id pub-id-type="pmid">16626397</pub-id></element-citation></ref>
<ref id="b43-mmr-16-06-9763"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marionnet</surname><given-names>C</given-names></name><name><surname>Pierrard</surname><given-names>C</given-names></name><name><surname>Lejeune</surname><given-names>F</given-names></name><name><surname>Sok</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Bernerd</surname><given-names>F</given-names></name></person-group><article-title>Different oxidative stress response in keratinocytes and fibroblasts of reconstructed skin exposed to non extreme daily-ultraviolet radiation</article-title><source>PLoS One</source><volume>5</volume><fpage>e12059</fpage><year>2010</year><pub-id pub-id-type="doi">10.1371/journal.pone.0012059</pub-id><pub-id pub-id-type="pmid">20706594</pub-id><pub-id pub-id-type="pmcid">2919404</pub-id></element-citation></ref>
<ref id="b44-mmr-16-06-9763"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>S</given-names></name><name><surname>Justiniano</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>DD</given-names></name><name><surname>Wondrak</surname><given-names>GT</given-names></name></person-group><article-title>The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV</article-title><source>Redox Biol</source><volume>1</volume><fpage>532</fpage><lpage>541</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.redox.2013.10.004</pub-id><pub-id pub-id-type="pmid">24273736</pub-id><pub-id pub-id-type="pmcid">3836278</pub-id></element-citation></ref>
<ref id="b45-mmr-16-06-9763"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saw</surname><given-names>CL</given-names></name><name><surname>Yang</surname><given-names>AY</given-names></name><name><surname>Huang</surname><given-names>MT</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Khor</surname><given-names>TO</given-names></name><name><surname>Su</surname><given-names>ZY</given-names></name><name><surname>Shu</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Conney</surname><given-names>AH</given-names></name><name><surname>Kong</surname><given-names>AN</given-names></name></person-group><article-title>Nrf2 null enhances UVB-induced skin inflammation and extracellular matrix damages</article-title><source>Cell Biosci</source><volume>4</volume><fpage>39</fpage><year>2014</year><pub-id pub-id-type="doi">10.1186/2045-3701-4-39</pub-id><pub-id pub-id-type="pmid">25228981</pub-id><pub-id pub-id-type="pmcid">4164960</pub-id></element-citation></ref>
<ref id="b46-mmr-16-06-9763"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panich</surname><given-names>U</given-names></name><name><surname>Sittithumcharee</surname><given-names>G</given-names></name><name><surname>Rathviboon</surname><given-names>N</given-names></name><name><surname>Jirawatnotai</surname><given-names>S</given-names></name></person-group><article-title>Ultraviolet radiation-induced skin aging: The role of DNA damage and oxidative stress in epidermal stem cell damage mediated skin aging</article-title><source>Stem Cells Int</source><volume>2016</volume><fpage>7370642</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/7370642</pub-id><pub-id pub-id-type="pmid">27148370</pub-id><pub-id pub-id-type="pmcid">4842382</pub-id></element-citation></ref>
<ref id="b47-mmr-16-06-9763"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagener</surname><given-names>FA</given-names></name><name><surname>Carels</surname><given-names>CE</given-names></name><name><surname>Lundvig</surname><given-names>DM</given-names></name></person-group><article-title>Targeting the redox balance in inflammatory skin conditions</article-title><source>Int J Mol Sci</source><volume>14</volume><fpage>9126</fpage><lpage>9167</lpage><year>2013</year><pub-id pub-id-type="doi">10.3390/ijms14059126</pub-id><pub-id pub-id-type="pmid">23624605</pub-id><pub-id pub-id-type="pmcid">3676777</pub-id></element-citation></ref>
<ref id="b48-mmr-16-06-9763"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>I</given-names></name><name><surname>Kinnula</surname><given-names>VL</given-names></name><name><surname>Gorbunova</surname><given-names>V</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name></person-group><article-title>SIRT1 as a therapeutic target in inflammaging of the pulmonary disease</article-title><source>Prev Med</source><volume>54</volume><supplement>Suppl</supplement><fpage>S20</fpage><lpage>S28</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.ypmed.2011.11.014</pub-id><pub-id pub-id-type="pmid">22178470</pub-id></element-citation></ref>
<ref id="b49-mmr-16-06-9763"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Rahman</surname><given-names>I</given-names></name></person-group><article-title>Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence</article-title><source>Biochem Pharmacol</source><volume>84</volume><fpage>1332</fpage><lpage>1339</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bcp.2012.06.031</pub-id><pub-id pub-id-type="pmid">22796566</pub-id><pub-id pub-id-type="pmcid">3482299</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-16-06-9763" position="float">
<label>Figure 1.</label>
<caption><p>Protective effects of RA against H<sub>2</sub>O<sub>2</sub> in NHDFs. (A) Evaluation of cytotoxicity in RA-treated NHDFs. Following 12 h of RA treatment, cell viability was evaluated using a water-soluble tetrazolium salt-based cytotoxicity assay. (B) RA mediated protective effects against H<sub>2</sub>O<sub>2</sub> cytotoxicity in NHDFs. Cells were pretreated with varying doses of RA for 12 h prior to exposure to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. Data are presented as the mean &#x00B1; standard deviation of relative cell viability from triplicate experiments. <sup>#</sup>P&#x003C;0.05 compared with non-treated control cells; &#x002A;P&#x003C;0.05 compared with H<sub>2</sub>O<sub>2</sub>-treated cells. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; NHDFs, normal human dermal fibroblasts; RA, rosmarinic acid.</p></caption>
<graphic xlink:href="MMR-16-06-9763-g00.tif"/>
</fig>
<fig id="f2-mmr-16-06-9763" position="float">
<label>Figure 2.</label>
<caption><p>Protective effects of RA against H<sub>2</sub>O<sub>2</sub>-mediated SA-&#x03B2;-gal activation in NHDFs. Cells were pretreated with the indicated doses of RA for 12 h prior to exposure to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 48 h. Cellular senescence was evaluated using an SA-&#x03B2;-gal assay. Data are presented as the mean &#x00B1; standard deviation from triplicate experiments. <sup>###</sup>P&#x003C;0.001 compared with non-treated control cells; &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01 compared with H<sub>2</sub>O<sub>2</sub>-treated cells. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; NHDFs, normal human dermal fibroblasts; RA, rosmarinic acid; SA-&#x03B2;-gal, senescence-associated &#x03B2;-galactosidase.</p></caption>
<graphic xlink:href="MMR-16-06-9763-g01.tif"/>
</fig>
<fig id="f3-mmr-16-06-9763" position="float">
<label>Figure 3.</label>
<caption><p>Antioxidative effects of RA in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs. (A) H<sub>2</sub>O<sub>2</sub> scavenging activity of &#x2265;1 mg/ml RA. L-ascorbic acid was used as the positive control. (B) Intracellular ROS scavenging activity of RA in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs. NAC was used as the positive control. (C) Effects of RA on nuclear factor erythroid-derived 2-like 2 transcriptional activity in H<sub>2</sub>O<sub>2</sub>-treated NHDFs. Transcriptional activity was evaluated using an antioxidant response element-luciferase reporter assay. (D) Effects of RA on the expression of antioxidant genes in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs. <italic>HO-1</italic>, <italic>SOD1</italic> and <italic>CAT</italic> mRNA expression levels were evaluated using quantitative polymerase chain reaction. Data are presented as the mean &#x00B1; standard deviation from triplicate experiments. <sup>###</sup>P&#x003C;0.001 compared with non-treated control cells; &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01 compared with H<sub>2</sub>O<sub>2</sub>-treated cells. <italic>CAT</italic>, catalase; DCF, 2&#x2032;7&#x2032;-dichlorofluorescein; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; <italic>HO-1</italic>, heme oxygenase-1; NAC, N-acetyl-cysteine; NHDFs, normal human dermal fibroblasts; RA, rosmarinic acid; <italic>SOD1</italic>, superoxide dismutase.</p></caption>
<graphic xlink:href="MMR-16-06-9763-g02.tif"/>
</fig>
<fig id="f4-mmr-16-06-9763" position="float">
<label>Figure 4.</label>
<caption><p>Effects of RA on the H<sub>2</sub>O<sub>2</sub>-induced inflammatory response in NHDFs. (A) Effects of RA on <italic>SIRT1</italic> expression in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs. <italic>SIRT1</italic> expression was evaluated using qPCR. (B) Effects of RA on NF-&#x03BA;B activity in fibroblasts. NF-&#x03BA;B activity was evaluated using an NF-&#x03BA;B-luciferase reporter assay. (C) Effects of RA on the expression of genes associated with inflammation in H<sub>2</sub>O<sub>2</sub>-exposed NHDFs. <italic>TNF-&#x03B1;</italic> and <italic>IL-6</italic> expression levels were evaluated using qPCR. Data are presented as the mean &#x00B1; standard deviation from triplicate experiments. <sup>#</sup>P&#x003C;0.05, <sup>##</sup>P&#x003C;0.01 compared with non-treated control cells; &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01 compared with H<sub>2</sub>O<sub>2</sub>-treated cells. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; <italic>IL-6</italic>, interleukin-6; NF-&#x03BA;B, nuclear factor-&#x03BA;B; NHDFs, normal human dermal fibroblasts; qPCR, quantitative polymerase chain reaction; RA, rosmarinic acid; <italic>SIRT1</italic>, sirtuin 1; <italic>TNF</italic>-&#x03B1;, tumor necrosis factor-&#x03B1;.</p></caption>
<graphic xlink:href="MMR-16-06-9763-g03.tif"/>
</fig>
<table-wrap id="tI-mmr-16-06-9763" position="float">
<label>Table I.</label>
<caption><p>Primer sequences for quantitative polymerase chain reaction.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Gene name</th>
<th align="center" valign="bottom">Gene symbol</th>
<th align="center" valign="bottom">Forward (5&#x2032;-3&#x2032;)</th>
<th align="center" valign="bottom">Reverse (5&#x2032;-3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Superoxide dismutase 1</td>
<td align="left" valign="top"><italic>SOD1</italic></td>
<td align="left" valign="top">GGGAGATGGCCCAACTACTG</td>
<td align="left" valign="top">CCAGTTGACATGCAACCGTT</td>
</tr>
<tr>
<td align="left" valign="top">Catalase</td>
<td align="left" valign="top"><italic>CAT</italic></td>
<td align="left" valign="top">ATGGTCCATGCTCTCAAACC</td>
<td align="left" valign="top">CAGGTCATCCAATAGGAAGG</td>
</tr>
<tr>
<td align="left" valign="top">Sirtuin 1</td>
<td align="left" valign="top"><italic>SIRT1</italic></td>
<td align="left" valign="top">GCAGGTTGCGGGAATCCAA</td>
<td align="left" valign="top">GGCAAGATGCTGTTGCAAA</td>
</tr>
<tr>
<td align="left" valign="top">Tumor necrosis factor-&#x03B1;</td>
<td align="left" valign="top"><italic>TNF-&#x03B1;</italic></td>
<td align="left" valign="top">CCCAGGGACCTCTCTCTAATC</td>
<td align="left" valign="top">GGTTTGCTACAACATGGGCTACA</td>
</tr>
<tr>
<td align="left" valign="top">Interleukin-6</td>
<td align="left" valign="top"><italic>IL-6</italic></td>
<td align="left" valign="top">TAACAGTTCCTGCATGGGCGGC</td>
<td align="left" valign="top">AGGACAGGCACAAACACGCACC</td>
</tr>
<tr>
<td align="left" valign="top">Actin, beta</td>
<td align="left" valign="top"><italic>&#x03B2;-actin</italic></td>
<td align="left" valign="top">GGATTCCTATGTGGGCGACGA</td>
<td align="left" valign="top">CGCTCGGTGAGGATCTTCATG</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>